 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Affy, Agilent, Illumina Affirm Commitment to Array Market in Light of Roche's Planned Exit
June 19, 2012
Affy, Agilent, Illumina Affirm Commitment to Array Market in Light of Roche's Planned Exit
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In Print: Last Month's Microarray Papers of Note
February 7, 2012 / BioArray News - Amid Market Exits and Acquisitions, 2012 Saw Arrays Gain Ground in Prenatal, DTC Markets
January 2, 2013 / BioArray News - Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests
December 11, 2012 / BioArray News - Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News - Cytogeneticists Say Platform Choice a Question of Personal Preference, Circumstance
August 21, 2012 / BioArray News